Targeting RAS-ERK pathway alterations with MEK inhibitors to improve chemosensitivity in high grade serous ovarian cancers
Article in Gynecologic Oncology (October 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Long term survival of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
Article in Translational Cancer Research (August 2021)
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
Article in Clinical Epigenetics (July 2021)